Davies, Jane C <br/><br/>
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Jun 2013 
 - 1219-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-4970 
<br/><br/><label>Standard No.: </label>10.1164/rccm.201301-0153OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Alleles<br/>Aminophenols--administration & dosage<br/>Child<br/>Cystic Fibrosis--drug therapy<br/>Cystic Fibrosis Transmembrane Conductance Regulator--genetics<br/>DNA--genetics<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Forced Expiratory Volume<br/>Humans<br/>Lung--physiopathology<br/>Mutation<br/>Quinolones--administration & dosage<br/>Respiratory Function Tests<br/>Treatment Outcome